Influenza A virus interacts extensively with the cellular SUMOylation system during infection

Virus Research

Volumn 158, Issue 1-2, 2011, Pages 12-27

  Pal, Sangita ^a,b   Santos, Andres ^a   Rosas, Juan M ^a,c   Ortiz Guzman, Joshua ^a   Rosas Acosta, Germán ^a  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

IFN; Influenza; Interferon; SUMO; SUMOylation; Ubc9; Virus infection; Virus host interactions

Indexed keywords

BETA INTERFERON; MATRIX PROTEIN; MATRIX PROTEIN M1; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; POLYMERASE BASIC PROTEIN 1; PROTEIN UBC9; SUMO 1 PROTEIN; SUMO PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CELL STIMULATION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLUENZA A; INFLUENZA VIRUS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MOLECULAR WEIGHT; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEIN TARGETING; SUMOYLATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION; VIRAL PROTEINS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 79956303456     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.02.017     Document Type: Article

References (60)

1. Bewig B., Schmidt W.E. Accelerated titering of adenoviruses. Biotechniques 2000, 28(5):870-873.
2. Boggio R., Chiocca S. Viruses and sumoylation: recent highlights. Curr. Opin. Microbiol. 2006, 9(4):430-436.
3. Bossis G., Malnou C.E., Farras R., Andermarcher E., Hipskind R., Rodriguez M., Schmidt D., Muller S., Jariel-Encontre I., Piechaczyk M. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol. Cell. Biol. 2005, 25(16):6964-6979.
4. Chalkiadaki A., Talianidis I. SUMO-dependent compartmentalization in promyelocytic leukemia protein nuclear bodies prevents the access of LRH-1 to chromatin. Mol. Cell. Biol. 2005, 25(12):5095-5105.
5. Chen G.W., Chang S.C., Mok C.K., Lo Y.L., Kung Y.N., Huang J.H., Shih Y.H., Wang J.Y., Chiang C., Chen C.J., Shih S.R. Genomic signatures of human versus avian influenza A viruses. Emerg. Infect. Dis. 2006, 12(9):1353-1360.
6. Chiocca S. Viral control of the SUMO pathway: Gam1, a model system. Biochem. Soc. Trans. 2007, 35(Pt. 6):1419-1421.
7. Desterro J.M., Rodriguez M.S., Hay R.T. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 1998, 2(2):233-239.
8. Diaz M.O., Ziemin S., Le Beau M.M., Pitha P., Smith S.D., Chilcote R.R., Rowley J.D. Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. U. S. A. 1988, 85(14):5259-5263.
9. Dohmen R.J. SUMO protein modification. Biochim. Biophys. Acta 2004, 1695(1-3):113-131.
10. Engelhardt O.G., Ullrich E., Kochs G., Haller O. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies. Exp. Cell Res. 2001, 271(2):286-295.
11. Garcia-Sastre A. Antiviral response in pandemic influenza viruses. Emerg. Infect. Dis. 2006, 12(1):44-47.
12. Geiss-Friedlander R., Melchior F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 2007, 8(12):947-956.
13. Geiss G.K., An M.C., Bumgarner R.E., Hammersmark E., Cunningham D., Katze M.G. Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J. Virol. 2001, 75(9):4321-4331.
14. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 2005, 15(5):536-541.
15. Girdwood D.W., Tatham M.H., Hay R.T. SUMO and transcriptional regulation. Semin. Cell Dev. Biol. 2004, 15(2):201-210.
16. Guo D., Han J., Adam B.L., Colburn N.H., Wang M.H., Dong Z., Eizirik D.L., She J.X., Wang C.Y. Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochem. Biophys. Res. Commun. 2005, 337(4):1308-1318.
17. Heiny A.T., Miotto O., Srinivasan K.N., Khan A.M., Zhang G.L., Brusic V., Tan T.W., August J.T. Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS One 2007, 2(11):e1190.
18. Hsiang T.Y., Zhao C., Krug R.M. Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J. Virol. 2009, 83(12):5971-5977.
19. Isaacson M.K., Ploegh H.L. Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe 2009, 5(6):559-570.
20. Jackson D.A., Caton A.J., McCready S.J., Cook P.R. Influenza virus RNA is synthesized at fixed sites in the nucleus. Nature 1982, 296(5855):366-368.
21. Johnson E.S. Protein modification by sumo. Annu. Rev. Biochem. 2004, 73:355-382.
22. Katze M.G., He Y., Gale M. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2002, 2(9):675-687.
23. Kim E.J., Park J.S., Um S.J. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1. Biochem. Biophys. Res. Commun. 2008, 377(3):952-956.
24. Kim Y.H., Sung K.S., Lee S.J., Kim Y.O., Choi C.Y., Kim Y. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1. FEBS Lett. 2005, 579(27):6272-6278.
25. Konig R., Stertz S., Zhou Y., Inoue A., Heinrich Hoffmann H., Bhattacharyya S., Alamares J.G., Tscherne D.M., Ortigoza M.B., Liang Y., Gao Q., Andrews S.E., Bandyopadhyay S., De Jesus P., Tu B.P., Pache L., Shih C., Orth A., Bonamy G., Miraglia L., Ideker T., Garcia-Sastre A., Young J.A., Palese P., Shaw M.L., Chanda S.K. Human host factors required for influenza virus replication. Nature 2009, 463(7282):813-817.
26. Krug R.M., Yuan W., Noah D.L., Latham A.G. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 2003, 309(2):181-189.
27. Kubota T., Matsuoka M., Chang T.H., Tailor P., Sasaki T., Tashiro M., Kato A., Ozato K. Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression. J. Biol. Chem. 2008, 283(37):25660-25670.
28. Lee Y.J., Castri P., Bembry J., Maric D., Auh S., Hallenbeck J.M. SUMOylation participates in induction of ischemic tolerance. J. Neurochem. 2009, 109(1):257-267.
29. Lee Y.J., Hallenbeck J.M. Insights into cytoprotection from ground squirrel hibernation, a natural model of tolerance to profound brain oligaemia. Biochem. Soc. Trans. 2006, 34(Pt. 6):1295-1298.
30. Lenschow D.J., Lai C., Frias-Staheli N., Giannakopoulos N.V., Lutz A., Wolff T., Osiak A., Levine B., Schmidt R.E., Garcia-Sastre A., Leib D.A., Pekosz A., Knobeloch K.P., Horak I., Virgin H.W.t. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(4):1371-1376.
31. Luo J., Deng Z.L., Luo X., Tang N., Song W.X., Chen J., Sharff K.A., Luu H.H., Haydon R.C., Kinzler K.W., Vogelstein B., He T.C. A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat. Protoc. 2007, 2(5):1236-1247.
32. Lyst M.J., Stancheva I. A role for SUMO modification in transcriptional repression and activation. Biochem. Soc. Trans. 2007, 35(Pt. 6):1389-1392.
33. Mabb A.M., Miyamoto S. SUMO and NF-kappaB ties. Cell. Mol. Life Sci. 2007, 64(15):1979-1996.
34. Mabb A.M., Wuerzberger-Davis S.M., Miyamoto S. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress. Nat. Cell Biol. 2006.
35. Manza L.L., Codreanu S.G., Stamer S.L., Smith D.L., Wells K.S., Roberts R.L., Liebler D.C. Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem. Res. Toxicol. 2004, 17(12):1706-1715.
36. Mossessova E., Lima C.D. Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. Mol. Cell 2000, 5(5):865-876.
37. Muller S., Matunis M.J., Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 1998, 17(1):61-70.
38. Nakagawa K., Yokosawa H. PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Lett. 2002, 530(1-3):204.
39. Nguyen H.V., Chen J.L., Zhong J., Kim K.J., Crandall E.D., Borok Z., Chen Y., Ann D.K. SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells. Am. J. Pathol. 2006, 168(5):1452-1463.
40. Owerbach D., McKay E.M., Yeh E.T., Gabbay K.H., Bohren K.M. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem. Biophys. Res. Commun. 2005, 337(2):517-520.
41. Pal S., Rosas J.M., Rosas-Acosta G. Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs. J. Virol. Methods 2009, 163(2):498-504.
42. Prokudina E.N., Semenova N.P., Chumakov V.M., Grigorieva T.A. Non-compact nucleocapsid protein multimers in influenza-virus-infected cells. Arch. Virol. 2007, 152(5):981-988.
43. Rosas-Acosta G., Langereis M.A., Deyrieux A., Wilson V.G. Proteins of the PIAS family enhance the sumoylation of the papillomavirus E1 protein. Virology 2005, 331(1):190-203.
44. Rosas-Acosta G., Russell W.K., Deyrieux A., Russell D.H., Wilson V.G. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell. Proteomics 2005, 4(1):56-72.
45. Rosas-Acosta G., Wilson V.G. Viruses and sumoylation. Sumoylation: Molecular Biology and Biochemistry 2004, 331-377. Horizon Bioscience, Norfolk, UK. V.G. Wilson (Ed.).
46. Saitoh H., Hinchey J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 2000, 275(9):6252-6258.
47. Sato Y., Yoshioka K., Suzuki C., Awashima S., Hosaka Y., Yewdell J., Kuroda K. Localization of influenza virus proteins to nuclear dot 10 structures in influenza virus-infected cells. Virology 2003, 310(1):29-40.
48. Shapira S.D., Gat-Viks I., Shum B.O., Dricot A., de Grace M.M., Wu L., Gupta P.B., Hao T., Silver S.J., Root D.E., Hill D.E., Regev A., Hacohen N. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139(7):1255-1267.
49. Smith G.P., Schultz D.A., Ladbury J.E. A ribonuclease S-peptide antagonist discovered with a bacteriophage display library. Gene 1993, 128(1):37-42.
50. Tang Y., Zhong G., Zhu L., Liu X., Shan Y., Feng H., Bu Z., Chen H., Wang C. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J. Immunol. 2010, 184(10):5777-5790.
51. Tempe D., Piechaczyk M., Bossis G. SUMO under stress. Biochem. Soc. Trans. 2008, 36(Pt. 5):874-878.
52. van Waardenburg R.C., Duda D.M., Lancaster C.S., Schulman B.A., Bjornsti M.A. Distinct functional domains of Ubc9 dictate cell survival and resistance to genotoxic stress. Mol. Cell. Biol. 2006, 26(13):4958-4969.
53. Verger A., Perdomo J., Crossley M. Modification with SUMO A role in transcriptional regulation. EMBO Rep. 2003, 4(2):137-142.
54. Vreede F.T., Fodor E. The role of the influenza virus RNA polymerase in host shut-off. Virulence 2010, 1(5):436-439.
55. Wolff T., Ludwig S. Influenza viruses control the vertebrate type I interferon system: factors, mechanisms, and consequences. J. Interferon Cytokine Res. 2009, 29(9):549-557.
56. Xu K., Klenk C., Liu B., Keiner B., Cheng J., Zheng B.J., Li L., Han Q., Wang C., Li T., Chen Z., Shu Y., Liu J., Klenk H.D., Sun B. Modification of nonstructural protein 1 of influenza A virus by SUMO1. J. Virol. 2011, 85(2):1086-1098.
57. Yanguez E., Nieto A. So similar, yet so different: selective translation of capped and polyadenylated viral mRNAs in the influenza virus infected cell. Virus Res. 2010.
58. Zhao C., Denison C., Huibregtse J.M., Gygi S., Krug R.M. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(29):10200-10205.
59. Zhao C., Hsiang T.Y., Kuo R.L., Krug R.M. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(5):2253-2258.
60. Zhong S., Muller S., Ronchetti S., Freemont P.S., Dejean A., Pandolfi P.P. Role of SUMO-1-modified PML in nuclear body formation. Blood 2000, 95(9):2748-2752.